Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA

Neoadjuvant treatment of breast cancer is applied to an increasing extent, but treatment response varies and side effects pose a challenge. The vitamin E isoform delta-tocotrienol might enhance the efficacy of chemotherapy and reduce the risk of side effects. The aim of this study was to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjær, Ina Mathilde, Kahns, Søren, Timm, Signe, Andersen, Rikke Fredslund, Madsen, Jonna Skov, Jakobsen, Erik Hugger, Tabor, Tomasz Piotr, Jakobsen, Anders, Bechmann, Troels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209064/
https://www.ncbi.nlm.nih.gov/pubmed/37225860
http://dx.doi.org/10.1038/s41598-023-35362-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209064/
https://www.ncbi.nlm.nih.gov/pubmed/37225860
http://dx.doi.org/10.1038/s41598-023-35362-7

Ejemplares similares